Trial · NCT01329029
Results by group74
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 74
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Rate of Moderate or Severe COPD Exacerbations Per Patient Per Year | Roflumilast 500 µg | 0.805 | 95% Confidence Interval 0.724 to 0.895 | exacerbations per patient per year | |
| Rate of Moderate or Severe COPD Exacerbations Per Patient Per Year | Placebo | 0.927 | 95% Confidence Interval 0.843 to 1.020 | exacerbations per patient per year | |
| Change From Baseline in Post-Bronchodilator Forced Expiratory Volume in the First Second (FEV1) | Roflumilast 500 µg | 0.052 | Standard Error 0.0064 | liters | |
| Change From Baseline in Post-Bronchodilator Forced Expiratory Volume in the First Second (FEV1) | Placebo | -0.004 | Standard Error 0.0062 | liters | |
| Rate of Severe COPD Exacerbations Per Patient Per Year | Roflumilast 500 µg | 0.239 | 95% Confidence Interval 0.201 to 0.283 | exacerbations per patient per year | |
| Rate of Severe COPD Exacerbations Per Patient Per Year | Placebo | 0.315 | 95% Confidence Interval 0.270 to 0.368 | exacerbations per patient per year | |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Roflumilast 500 µg | Moderate | 0.574 | 95% Confidence Interval 0.508 to 0.648 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Placebo | Moderate | 0.627 | 95% Confidence Interval 0.561 to 0.702 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Roflumilast 500 µg | Mild, Moderate or Severe | 3.078 | 95% Confidence Interval 2.723 to 3.479 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Placebo | Mild, Moderate or Severe | 3.879 | 95% Confidence Interval 3.492 to 4.310 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Roflumilast 500 µg | Leading to Hospitalisation | 0.238 | 95% Confidence Interval 0.200 to 0.283 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Placebo | Leading to Hospitalisation | 0.313 | 95% Confidence Interval 0.268 to 0.365 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Roflumilast 500 µg | Glucocorticosteroids and/or Antibiotics treatment | 0.794 | 95% Confidence Interval 0.716 to 0.88 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Placebo | Glucocorticosteroids and/or Antibiotics treatment | 0.929 | 95% Confidence Interval 0.847 to 1.019 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Roflumilast 500 µg | Moderate or Severe and/or treated with Antibiotics | 1.012 | 95% Confidence Interval 0.922 to 1.110 | exacerbations per patient per year |
| Rate of COPD Exacerbations Per Patient Per Year All Categories | Placebo | Moderate or Severe and/or treated with Antibiotics | 1.210 | 95% Confidence Interval 1.115 to 1.313 | exacerbations per patient per year |
| Percentage of Participants Experiencing at Least 1 COPD Exacerbation | Roflumilast 500 µg | 55.2 | percentage of participants | ||
| Percentage of Participants Experiencing at Least 1 COPD Exacerbation | Placebo | 60.5 | percentage of participants | ||
| Time to First COPD Exacerbation All Categories | Roflumilast 500 µg | 218.0 | 95% Confidence Interval 189.0 to 259.0 | days | |
| Time to First COPD Exacerbation All Categories | Placebo | 180.0 | 95% Confidence Interval 147.0 to 200.0 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01329029/results